...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >Neural Dynamics of Multiple Object Processing in Mild Cognitive Impairment and Alzheimer's Disease: Future Early Diagnostic Biomarkers?
【24h】

Neural Dynamics of Multiple Object Processing in Mild Cognitive Impairment and Alzheimer's Disease: Future Early Diagnostic Biomarkers?

机译:轻度认知障碍和阿尔茨海默病中多对象处理的神经动力学:未来早期诊断生物标志物?

获取原文
获取原文并翻译 | 示例

摘要

The aim of this study was to investigate the behavioral and electrophysiological dynamics of multiple object processing (MOP) in mild cognitive impairment (MCI) and Alzheimer's disease (AD), and to test whether its neural signatures may represent reliable diagnostic biomarkers. Behavioral performance and event-related potentials [N2pc and contralateral delay activity (CDA)] were measured in AD, MCI, and healthy controls during a MOP task, which consisted in enumerating a variable number of targets presented among distractors. AD patients showed an overall decline in accuracy for both small and large target quantities, whereas in MCI patients, only enumeration of large quantities was impaired. N2pc, a neural marker of attentive individuation, was spared in both AD and MCI patients. In contrast, CDA, which indexes visual short term memory abilities, was altered in both groups of patients, with a non-linear pattern of amplitude modulation along the continuum of the disease: a reduction in AD and an increase in MCI. These results indicate that AD pathology shows a progressive decline in MOP, which is associated to the decay of visual short-term memory mechanisms. Crucially, CDA may be considered as a useful neural signature both to distinguish between healthy and pathological aging and to characterize the different stages along the AD continuum, possibly becoming a reliable candidate for an early diagnostic biomarker of AD pathology.
机译:本研究的目的是研究轻度认知障碍(MCI)和阿尔茨海默病(AD)中多个物体处理(MOP)的行为和电生理动态,并测试其神经签名是否可代表可靠的诊断生物标志物。在AD,MCI和健康对照期间,在AD,MCI和健康控制中测量了行为性能和事件相关的电位[N2PC和对侧延迟活动(CDA)],该任务在枚举了分散的人中呈现的可变数量的目标中。 AD患者对小型和大型目标数量的准确性表现出总体下降,而在MCI患者中,只有大量的枚举才受到损害。 N2PC是一部分细胞分子的神经标记,在AD和MCI患者中避免。相比之下,指定视觉短期记忆能力的CDA在两组患者中改变,沿着疾病连续的振幅调节的非线性模式:AD的减少和MCI的增加。这些结果表明,AD病理学表现出拖把的逐步下降,与视觉短期内存机制的衰减相关。至关重要的是,CDA可以被认为是区分健康和病理老化的有用神经签名,并沿着广告连续统一的不同阶段表征不同的阶段,可能成为广告病理早期诊断生物标志物的可靠候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号